Sort
1,049,261 grants matching “t cell”
Biological Diversity: Generation, Control and Exploitation
$3,144,090Andrew W Murray · Harvard University · P50 · FY2009 · GM
Integrative labeling, imaging, and reconstruction tools for high-throughput inhibitory microconnectivity analysis in the mouse brain
$3,144,081Dawen Cai · University Of Michigan At Ann Arbor · RF1 · FY2020 · MH
Multi-scale Complex Systems Transdisciplinary Analysis of Response to Therapy (MC
$3,144,049William Daniel Hillis · University Of Southern California · U54 · FY2010 · CA
Cellular Immunity to Category A-C Viruses in Humans
$3,143,817Robert William Finberg · Univ Of Massachusetts Med Sch Worcester · U19 · FY2012 · AI
Center for Serological Testing to Improve Outcomes from Pandemic COVID-19 (STOP-COVID)
$3,143,795Eugene M. Oltz · Ohio State University · U54 · FY2023 · CA
Opposing Regulation of Sleep-Wake Abeta Fluctuations by Orexin and Dynorphin
$3,142,615John R Cirrito · Washington University · RF1 · FY2019 · AG
Solid Organ Transplantation in HIV: Multi-Site Study
$3,142,602Peter G Stock · University Of California, San Francisco · U01 · FY2007 · AI
Complications of Hemolysis and Transfusion Therapy
$3,142,533Karina Yazdanbakhsh · New York Blood Center · P01 · FY2020 · HL
Genomics Of Acute Myeloid Leukemia.
$3,142,107Timothy J Ley · Washington University · P01 · FY2020 · CA
TCR Gene Modified T Cells for Adoptive Immunotherapy
$3,141,645Michael I Nishimura · Loyola University Chicago · P01 · FY2013 · CA
Human Dendritic Cells and In Vivo Immunity to Biothreat
$3,141,637Jacques F Banchereau · Baylor Research Institute · U19 · FY2007 · AI
Human Dendritic Cells and In Vivo Immunity to Biothreat
$3,141,637Jacques F Banchereau · Baylor Research Institute · U19 · FY2008 · AI
Eukaryotic Transcriptional Regulation
$3,141,632Paul A Wade · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Monospecific monoclonal antibodies against human transcription factors
$3,141,583Jef D Boeke · Johns Hopkins University · U54 · FY2011 · HG
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
$3,141,483Richard M Weinshilboum · Mayo Clinic Rochester · U19 · FY2014 · GM
Treatment of Infections in Immunocompromised Children with Cancer, Hematopoietic
$3,141,379Thomas J Walsh · Clinical Sciences · Z01 · FY2007 · CA
THE OBJECTIVE OF THIS PROPOSAL IS TO DEMONSTRATE LOW-TEMPERATURE HYDROGEN PRODUCTION FROM PROTON CONDUCTING SOLID OXIDE ELECTROLYSIS CELL (P-SOEC) TECHNOLOGY WITH ENHANCED ACTIVITY, EFFICIENCY, AND DURABILITY THROUGH A SERIES OF WORK IN MATERIALS DEVELOPMENT, INTERFACE ENGINEERING, MANUFACTURING IMPROVEMENT, DEGRADATION STUDY, AND FARADAIC EFFICIENCY. BY THE END OF BUDGET PERIOD 1, THE TEAM WILL 1) DEMONSTRATE THE ACTIVE AND DURABLE P-SOEC MATERIAL SYSTEM BASED ON TRIPLE CONDUCTING OXYGEN ELECTRODE AND BARIUM-ZIRCONATE ELECTROLYTE WITH COMPATIBLE THERMAL AND CHEMICAL PROPERTIES, 2) IDENTIFY SURFACE CHEMISTRY AND ELECTRODE DEGRADATION MECHANISMS ON SURFACE, 3) DEMONSTRATE LARGE-SCALE SINGLE-CELL CELL MANUFACTURING WITH OPTIMAL PROTOCOLS. BY THE END OF BUDGET PERIOD 2, THE TEAM WILL 1) DEMONSTRATE ENHANCED MECHANICAL STRENGTH, INTERFACIAL BONDING, AND POLARIZATION RESISTANCE FOR OPTIMIZED ELECTROCHEMICAL ACTIVITY, 2) DELIVER DEEP UNDERSTANDING ON THE PHASE EVOLUTION DURING ELECTROLYSIS FOR SUPPRESSING INTERFACIAL DEGRADATION, 3) IMPROVE MANUFACTURING READINESS AND DEMONSTRATE A P-SOEC SHORT STACK FOR ELECTROLYSIS OPERATION. BY THE END OF BUDGET PERIOD 3, THE TEAM WILL 1) DEMONSTRATE THE IMPROVEMENT OF FARADAIC EFFICIENCY BY INTERFACE ENGINEERING TO ELIMINATE ELECTRONIC LEAKAGE, 2) SUCCESSFULLY DESIGN AN INTERFACE FOR ELIMINATING LONG-TERM DEGRADATION BY UNDERSTANDING THE FAILURE MECHANISM AND PROVIDING COST-EFFECTIVE APPROACH, 3) DELIVER 500-W P-SOEC STACK FOR ELECTROLYSIS OPERATION.
$3,141,250University Of Oklahoma · · FY2025 · Department of Energy
Harnessing Novel Human Endocrine Progenitor Biology for Enhanced Generation of Beta Cells from Stem Cells
$3,140,632Julie Beth Sneddon · University Of California, San Francisco · R01 · FY2025 · DK
South Dakota Biomedical Research Infrastructure Network
$3,140,484Barbara E Goodman · University Of South Dakota · P20 · FY2012 · GM
Neurobiology and Cognitive Role of Slow Brain Network Fluctuations
$3,140,199Charles E Schroeder · Nathan S. Kline Institute For Psych Res · P50 · FY2025 · MH
Laboratory of Molecular Imaging and Nanomedicine
$3,139,811Xiaoyuan Chen · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2011 · EB
Gating mechanisms and pharmacology of voltage-activated ion channels
$3,139,557Kenton Swartz · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Human neuropeptide transmitter systems are dysregulated in Alzheimer's disease pathogenesis
$3,138,871Vivian Y. H. Hook · University Of California, San Diego · RF1 · FY2025 · AG
The National Person-Centered Assessment Resource (PCAR)
$3,138,774David Cella · Northwestern University At Chicago · U2C · FY2015 · CA
Center for Precision Medicine in Leukemia (CPML)
$3,138,729Mary V. Relling · St. Jude Children'S Research Hospital · P50 · FY2015 · GM